Literature DB >> 9606575

The ethical basis of psychiatric research: conceptual issues and empirical findings.

L W Roberts1.   

Abstract

The study objective was to clarify the ethical basis of psychiatric research by outlining conceptual issues and empirical findings related to the ethics of human experimentation. A systematic review of scholarly and empirical literature covering three decades was performed. The ethics of human research has come to be understood in relation to the principles of respect for persons, beneficence, justice, and the ideal of informed consent. Subjects who cannot fully participate in informed-consent processes are especially vulnerable to exploitation. Current dilemmas stem from insufficient attention to the vulnerabilities of mentally ill research participants, problems in applying ethical concepts and guidelines to psychiatric research, and claims of research misconduct. Empirical studies indicate that (1) psychiatric symptoms significantly affect informed consent, (2) psychiatric patients may possess certain strengths with respect to research involvement, (3) proxy decision-making is problematic, (4) informed consent is also difficult to attain with the medically ill and others, (5) patients are motivated to participate in research by the hope of personal benefit, (6) ethical aspects of research are poorly documented, and (7) institutional review processes may not be adequate to protect vulnerable subjects. Psychiatric research can be performed ethically, according to standards set throughout the biomedical and behavioral sciences, so long as researchers and institutions are respectful of special ethical issues in human experimentation and strive to include vulnerable study participants fully in research decisions. However, many gaps in the empirical literature exist regarding the specific nature and implementation of ethics principles in psychiatric research. Efforts to advance both science and ethics, including the study of ethical dimensions of human research itself, are essential for the future of psychiatry.

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh:

Year:  1998        PMID: 9606575     DOI: 10.1016/s0010-440x(98)90068-2

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  14 in total

1.  Screening for understanding of research in the inpatient psychiatry setting.

Authors:  Norval J Hickman; Judith J Prochaska; Laura B Dunn
Journal:  J Empir Res Hum Res Ethics       Date:  2011-09       Impact factor: 1.742

2.  Ethical considerations in mental health research with racial and ethnic minority communities.

Authors:  Charmaine C Williams
Journal:  Community Ment Health J       Date:  2005-10

Review 3.  Emerging empirical evidence on the ethics of schizophrenia research.

Authors:  Laura B Dunn; Philip J Candilis; Laura Weiss Roberts
Journal:  Schizophr Bull       Date:  2005-10-19       Impact factor: 9.306

4.  Do research procedures pose relatively greater risk for healthy persons than for persons with schizophrenia?

Authors:  Laura Weiss Roberts; Laura B Dunn; Katherine A Green Hammond; Teddy D Warner
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

5.  Depressive symptoms among surrogate decision makers in Lebanese ICUs.

Authors:  Fadi Abou-Mrad; Charbel Mourad; Catherine Najem
Journal:  Funct Neurol       Date:  2012 Apr-Jun

6.  Ethical Issues in Deep Brain Stimulation Research for Treatment-Resistant Depression: Focus on Risk and Consent.

Authors:  Laura B Dunn; Paul E Holtzheimer; Jinger G Hoop; Helen S Mayberg; Paul S Appelbaum
Journal:  AJOB Neurosci       Date:  2011

7.  Mental Health Research in Correctional Settings: Perceptions of Risk and Vulnerabilities.

Authors:  Mark E Johnson; Karli K Kondo; Christiane Brems; Erica F Ironside; Gloria D Eldridge
Journal:  Ethics Behav       Date:  2015-02-19

8.  Problem areas in the understanding of informed consent for research: study of middle-aged and older patients with psychotic disorders.

Authors:  Laura B Dunn; Dilip V Jeste
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

9.  Paradigm shifts in disability and health: toward more ethical public health research.

Authors:  Katherine E McDonald; Dora M Raymaker
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

Review 10.  Placebo-related effects in clinical trials in schizophrenia: what is driving this phenomenon and what can be done to minimize it?

Authors:  Larry Alphs; Fabrizio Benedetti; W Wolfgang Fleischhacker; John M Kane
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-05       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.